News

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
The FDA also expanded the use of Advair Diskus 250/50 to a broader patient population which includes not only patients with COPD associated with chronic bronchitis, but also emphysema or both ...
Advair 250/50 was prescribed for me over 10 years ago, and I’ve been taking it regularly each morning, thoroughly rinsing each time to prevent thrush. About five years ago, I developed an ...
Co annonces the FDA has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus in the ... the currently approved 250/50 strength in order ...
Advair, on the other hand, comes in two forms: Advair HFA and Advair Diskus. Advair HFA is an aerosol inhaler that contains a propellant to help the medication reach your lungs. Advair Diskus ...
250/50 mcg and 500/50 mcg) to the U.S. Food and Drug Administration (FDA), by its strategic alliance partner, Respirent Pharmaceuticals Co. Ltd. The product is the generic equivalent of ADVAIR ...
RESEARCH TRIANGLE PARK, N.C., May 1 /PRNewswire-FirstCall/ -- Late yesterday the U.S. Food and Drug Administration approved Advair Diskus(R) 250/50 (fluticasone ...
RESEARCH TRIANGLE PARK, N.C., April 30 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration today approved Advair Diskus(R) 250/50 (fluticasone propionate ...
RESEARCH TRIANGLE PARK, N.C., May 1 Lateyesterday the U.S. Food and Drug Administration approved Advair Diskus(R)250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalationpowder ...